Guggenheim analyst Chris Pasquale lowered the price target on Medtronic, Inc. (NYSE: MDT) to $142.00 (from $148.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Medtronic, Inc. (MDT) PT Lowered to $145 at UBSNovember 24, 2021 7:40 AM Medtronic, Inc. (MDT) PT Lowered to $145 at OppenheimerNovember 24, 2021 5:42 AM Medtronic, Inc. (MDT) PT Lowered to $146 at CitiNovember 24, 2021 5:41 AM Medtronic, Inc. (MDT) PT Lowered to $138 at BTIGNovember 24, 2021 5:33 AM UPDATE: Medtronic, Inc. (MDT) PT Lowered to $145 at Morgan Stanley as Growth is Pushed into 2023+November 24, 2021 2:37 AM Medtronic, Inc. (MDT) PT Lowered to $140 at StifelNovember 23, 2021 5:49 PM Medtronic, Inc. (MDT) PT Lowered to $145 at Needham & CompanyNovember 23, 2021 1:27 PM Medtronic (MDT) Tops Q2 EPS by 3c, Maintains FY EPS GuidanceNovember 23, 2021 6:46 AM Medtronic Reports Second Quarter Fiscal 2022 Financial ResultsNovember 23, 2021 6:45 AM